BioRestorative Therapies Gross Profit vs. EBITDA
| BRTX Stock | USD 1.45 0.01 0.68% |
Gross Profit | First Reported 2012-06-30 | Previous Quarter 82.6 K | Current Value 215.4 K | Quarterly Volatility 51 K |
For BioRestorative Therapies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioRestorative Therapies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioRestorative Therapies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioRestorative Therapies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioRestorative Therapies over time as well as its relative position and ranking within its peers.
BioRestorative |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioRestorative Therapies. If investors know BioRestorative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioRestorative Therapies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.38) | Revenue Per Share 0.055 | Quarterly Revenue Growth 6.609 | Return On Assets (0.53) | Return On Equity (0.17) |
The market value of BioRestorative Therapies is measured differently than its book value, which is the value of BioRestorative that is recorded on the company's balance sheet. Investors also form their own opinion of BioRestorative Therapies' value that differs from its market value or its book value, called intrinsic value, which is BioRestorative Therapies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioRestorative Therapies' market value can be influenced by many factors that don't directly affect BioRestorative Therapies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioRestorative Therapies' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioRestorative Therapies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioRestorative Therapies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioRestorative Therapies EBITDA vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioRestorative Therapies's current stock value. Our valuation model uses many indicators to compare BioRestorative Therapies value to that of its competitors to determine the firm's financial worth. BioRestorative Therapies is rated fourth in gross profit category among its peers. It is rated below average in ebitda category among its peers . At this time, BioRestorative Therapies' Gross Profit is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioRestorative Therapies' earnings, one of the primary drivers of an investment's value.BioRestorative EBITDA vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
BioRestorative Therapies |
| = | 119.8 K |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
BioRestorative Therapies |
| = | (15.06 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
BioRestorative EBITDA Comparison
BioRestorative Therapies is currently under evaluation in ebitda category among its peers.
BioRestorative Therapies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioRestorative Therapies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioRestorative Therapies will eventually generate negative long term returns. The profitability progress is the general direction of BioRestorative Therapies' change in net profit over the period of time. It can combine multiple indicators of BioRestorative Therapies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -15.2 M | -14.5 M | |
| Income Before Tax | -10.4 M | -10.9 M | |
| Total Other Income Expense Net | 4.8 M | 5 M | |
| Net Loss | -10.4 M | -10.9 M | |
| Income Tax Expense | (5.00) | (5.25) | |
| Net Loss | -15.9 M | -16.7 M | |
| Net Loss | -16.6 M | -17.5 M | |
| Net Interest Income | 292.2 K | 306.8 K | |
| Non Operating Income Net Other | -6.2 M | -6.5 M | |
| Change To Netincome | 14.4 M | 8.8 M | |
| Net Loss | (2.47) | (2.59) | |
| Income Quality | 0.62 | 0.47 | |
| Net Income Per E B T | 1.12 | 1.09 |
BioRestorative Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioRestorative Therapies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioRestorative Therapies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioRestorative Therapies' important profitability drivers and their relationship over time.
Use BioRestorative Therapies in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioRestorative Therapies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioRestorative Therapies will appreciate offsetting losses from the drop in the long position's value.BioRestorative Therapies Pair Trading
BioRestorative Therapies Pair Trading Analysis
The ability to find closely correlated positions to BioRestorative Therapies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioRestorative Therapies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioRestorative Therapies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioRestorative Therapies to buy it.
The correlation of BioRestorative Therapies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioRestorative Therapies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioRestorative Therapies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioRestorative Therapies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioRestorative Therapies position
In addition to having BioRestorative Therapies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Heavy Metals Thematic Idea Now
Heavy Metals
Companies involved in mining, production, and distribution of various industrial metals and minerals. The Heavy Metals theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Heavy Metals Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioRestorative Stock Analysis
When running BioRestorative Therapies' price analysis, check to measure BioRestorative Therapies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRestorative Therapies is operating at the current time. Most of BioRestorative Therapies' value examination focuses on studying past and present price action to predict the probability of BioRestorative Therapies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRestorative Therapies' price. Additionally, you may evaluate how the addition of BioRestorative Therapies to your portfolios can decrease your overall portfolio volatility.